SPEAKER FACULTY

Anton Pekcec

Director, Cardiometabolic Diseases Research

Boehringer Ingelheim

Cory Schwartz

Director, Research and Early Development

iBio

David Bearss

President & Chief Executive Officer ,Co-Founder

Halia Therapeutics

David Tingley

Founder

Olio Labs

Gary Barnette

Chief Scientific Officer

Veru Inc.

Gordon Foulkes

Chief Executive Officer

Lipidio Pharmaceuticals

Ilan Zipkin

Chief Executive Officer

Supercede Therapeutics

Jeremiah Bearss

Chief Medical Officer

Biolexis Therapeutics

John Mayer

Chief Scientific Officer

Ambrosia Biosciences

Julia Dunn

Executive Director - Medical

Eli Lily

Laurent Audoly

Chief Executive Officer

Prive Bio

Marco Falasca

Professor Biochemistry, Medicine and Surgery

University of Parma

Martin Marro

Executive Director, Cell Pharmacology, Obesity & Complications

Eli Lily

Mitchell Steiner

Chairman, Chief Executive Officer & President

Veru Inc.

Patrice Lee

Head of R&D and Pharmacology

Ambrosia Biosciences

Raj Reddy

Chief Executive Officer

Canary Global

Robert Schott

Chief Medical Officer

Rivus Pharmaceuticals Inc.

Sara Gry Vienberg

Senior Scientist, Diabetes Biology

Novo Nordisk

Tom Hardy

Chief Medical Officer

Adipo Therapeutics